Introduction: The acute respiratory distress syndrome (ARDS) is a common and catastrophic
condition, with a high mortality rate and economic burden on society. Despite 50 years of …

The acute respiratory distress syndrome (ARDS) is a clinical syndrome with primarily
supportive management options. Despite extensive basic and clinical investigations …

Overall, there is no proven pharmacological therapy in ARDS, but some pharmacological
interventions were associated with beneficial effects in certain subgroups of patients …

Pharmacological treatments for acute respiratory distress sy... : Current Opinion in Critical Care
Pharmacological treatments for acute respiratory distress syndrome : Current Opinion in …

Introduction: Pharmacotherapy for the acute respiratory distress syndrome (ARDS) has been
tested in preclinical and clinical studies. However, to date, no pharmacological interventions …

Introduction: Acute respiratory distress syndromes (ARDS) are devastating disorders of
overwhelming pulmonary inflammation and hypoxemia, resulting in high morbidity and …

Acute respiratory distress syndrome (ARDS) is an inflammatory process caused by a variety
of direct and indirect injuries to the lungs. Despite improvements in supportive care and …

Despite its high incidence and devastating outcomes, acute respiratory distress syndrome
(ARDS) has no specific treatment, with effective therapy currently limited to minimizing …

The acute respiratory distress syndrome (ARDS) remains a common and highly morbid
condition despite advances in the understanding and management of this complex critical …

Despite 50 years of extensive research, no definite drug is currently available to treat acute
respiratory distress syndrome (ARDS), and the supportive therapies remain the mainstay of …